Authors:
Baekelandt, M
Lehne, G
Trope, CG
Szanto, I
Pfeiffer, P
Gustavssson, B
Kristensen, GB
Citation: M. Baekelandt et al., Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer, J CL ONCOL, 19(12), 2001, pp. 2983-2993
Authors:
Laupeze, B
Amiot, L
Bertho, N
Grosset, JM
Lehne, G
Fauchet, R
Fardel, O
Citation: B. Laupeze et al., Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells, HUMAN IMMUN, 62(10), 2001, pp. 1073-1080
Authors:
Laupeze, B
Amiot, L
Payen, L
Drenou, B
Grosset, JM
Lehne, G
Fauchet, R
Fardel, O
Citation: B. Laupeze et al., Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood, LIFE SCI, 68(11), 2001, pp. 1323-1331
Authors:
Lehne, G
Morkrid, L
den Boer, M
Rugstad, HE
Citation: G. Lehne et al., Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP), INT J CL PH, 38(4), 2000, pp. 187-195
Authors:
Lehne, G
De Angelis, P
den Boer, M
Rugstad, HE
Citation: G. Lehne et al., Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents, LEUKEMIA, 13(5), 1999, pp. 768-778